Hanx Biopharmaceuticals (Wuhan) , Ltd. Goodwill

Hanx Biopharmaceuticals (Wuhan) , Ltd. (3378.HK) currently reports a goodwill of $0 as of June 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Hanx Biopharmaceuticals (Wuhan) , Ltd.'s goodwill history and peer comparisons.

Hanx Biopharmaceuticals (Wuhan) , Ltd.'s goodwill changed from $0 to $0 (period ending June 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hanx Biopharmaceuticals (Wuhan) , Ltd. reported $0 in goodwill as of June 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current goodwill of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hanx Biopharmaceuticals (Wuhan) , Ltd., and consider following 3378.HK for alerts when major investors trade the stock.

Hanx Biopharmaceuticals (Wuhan) , Ltd. is classified in the Healthcare sector. On goodwill, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 3378.HK with unrelated industries.